Genprex, Inc. Gains 51.52%

Tue 05 May 20 at 05:30 PM
Genprex, Inc. Gains 51.52%

Genprex, Inc. (GNPX:NASDAQ) rocketted at $3.5, a gain of 51.5%. The stock got featured on our News Catalysts scanner on Tue 21 Apr 20 at 11:57 AM in the 'BIOTECH' category. From Mon 20 Apr 20, the stock recorded 50.00% Up Days and 45.45% Green Days

The share price of the company has been moving sideways in recent weeks.

About Genprex, Inc. (GNPX:NASDAQ)

Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.